MEDBOT-B's stock price fell sharply by 5.00% during intraday trading on Friday, as the market reacted to a significant change in the company's share structure.
The decline followed the company's announcement that it had completed the conversion of 5,989,798 unlisted shares into H shares, with trading of these newly converted shares commencing at the start of the session. This conversion increased the total number of H shares outstanding, raising concerns among investors about potential dilution and increased selling pressure.